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Trauma caused by motor vehicle collisions (MVCs) is currently the third most common cause of death globally, 
with 90% of these deaths occurring in developing 
countries including Oman. In fact, Oman has one of 
the highest rates of deaths from MVCs in the world, 
with a mortality rate of 20–30 per 100,000.1
Some injuries may be evident at the time of 
admission, while another class of injuries may 
remain occult for some time and then become 
evident when it may be too late for any intervention. 
Blunt cerebrovascular injuries (BCVIs) are one 
of the occult injuries caused by blunt trauma. They 
are considered to be relatively uncommon; however, 
they carry a high rate of mortality and morbidity if 
they remain undetected. 
BCVIs may or may not initially present with 
symptoms or signs that warrant suspicion of such 
injuries and therefore the provision of adequate 
diagnostic investigations and management is 
crucial. The realisation of this fact led to increased 
awareness of the amplitude of such injuries and the 
need to establish adequate screening criteria and 
cost-effective screening modalities.
If symptoms do present, however, they are 
usually attributable to focal neurological deficits 
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اإلصابات الَكليَلة لألوعية الدموية يف الرأس والرقبة
مراجعة األدبيات
عبد اهلل احلارثي، الرمي الهنائي، خليفة الوهيبي، هاين القا�ضي
امللخ�ص: لقد نالت الإ�ضابات الَكليَلة للأوعية الدموية يف الراأ�س والرقبة اهتمام العديد من الباحثني عامليًا، ويت�ضح ذلك من الكمية 
النتائج  خطورة  اإىل  ُيعزى  قد  الإ�ضابات  هذه  به  حظيت  الذي  الهتمام  اإن  املعروفة.  البحث  حمركات  يف  املتوافرة  للأدبيات  الهائلة 
املرتبطة بها من ناحية معدلت الوفيات واملرا�ضة التي ت�ضيب الذين يتعر�ضون لها، خا�ضة مع اإمكانية ت�ضخي�ضها وجتنب م�ضاعفاتها 
با�ضتخدام اأجهزة الأ�ضعة املتطورة. اإن اخلطوة الأهم يف عملية جتنب عواقب هذه الإ�ضابات هو ت�ضخي�ضها املبكر بوا�ضطة فحو�ضات يتم 
اإجراوؤها اعتماداً على اآلية الإ�ضابة الأكرث ارتباطًا بالإ�ضابات الكليلة للأوعية الدموية يف الراأ�س والرقبة. نعر�س هنا مراجعة �ضاملة 
فيما يتعلق باآلية الإ�ضابة والت�ضوير ال�ضعاعي والعلج يف حالت الإ�ضابات الكليلة، ومت حتديد املقالت من خلل البحث يف ال�ضبكة 
الفقري،  ال�ضباتي،  الآتية: كليلة، وعائية،  الرئي�ضية  الكلمات  ال�ضواهد با�ضتخدام  الطبية و�ضجل كوكرين املركزي للتجارب ذات  العاملية 
ال�ضدمة، ال�ضكتة الدماغية، تدابري علجية، وق�ضطرة جراحية.
مفتاح الكلمات: وعائي، �ضباتي، فقري، اإ�ضابة، �ضكتة دماغية، علج، ق�ضطرة جراحية.
abstract: Blunt cerebrovascular injuries (BCVI) have been a topic of interest to many researchers worldwide 
as evidenced by the vast amount of available literature. The interest in these rare injuries is probably due to the 
significant possibility of mortality and morbidity amongst patients who sustain them, when the employment 
of radiological screening methods could prevent such an outcome. Recognition of these injuries is the most 
important step towards prevention of adverse outcomes. We present a comprehensive review of the literature 
regarding the mechanism of injury, imaging, management, and complications of BCVI. Articles were identified 
through a search of MEDLINE and the Cochrane Central Register of Controlled Trials using the keywords Blunt; 
Vascular; Carotid; Vertebral; Trauma; Stroke; Management, and Endovascular. The search was limited to humans 
and articles in English. 
Keywords: Vascular; Carotid; Vertebral; Trauma; Stroke; Management; Endovascular.
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caused by ischaemia of the carotid or vertebral 
artery territories, or are due to a traumatic carotid-
cavernous fistula manifesting as orbital pain, 
proptosis, hyperaemia, cerebral swelling, or seizure.2
Incidence of BCVIs
The general incidence of BCVIs amongst all trauma 
admissions has been reported in the literature 
as <1%. The incidence of blunt carotid artery 
injuries (BCIs) reported in the literature ranges 
from 0.08–0.27% while the incidence of blunt 
vertebral artery injuries (BVIs) ranges from 0.20% 
to 0.77%.3,4 Although these patients are a small 
fraction of all trauma patients, they carry risks of 
stroke and mortality that are as high as 58% and 59% 
respectively.5,6,7
Mechanism of Injury
The three basic mechanisms of injury to 
the cerebrovascular vessels are: 1) Severe 
hyperextension and rotation; 2) Direct blow to the 
vessel, and 3) Vessel laceration by adjacent bone 
fractures.2 Injuries to the extracranial carotid artery 
are most commonly due to hyperextension of the 
vessel over the lateral articular processes of C 1–3 
at the base of the skull. Direct blows to the vessels 
in seat-belt injuries and hanging attempts are also 
possible causes. Injuries to the intracranial segment 
of the carotid artery are mostly due to basal skull 
fractures.2 Vertebral artery injuries occur most 
commonly in fractures involving the course of the 
vessel through the transverse foramina of C 2–6.8
Pathogenesis
With any of the mechanisms of injury mentioned 
above, the pathological changes in the vessels are that 
of intimal disruption, dissection, pseudoaneurysm 
formation, carotid-cavernous fistula, thrombosis 
and complete transection of the artery.2,3 The 
resultant ischaemia caused by these injuries is 
thought to be due to the following: 1) Dissection 
of the artery causing haemodynamic instability, 
and 2) Intimal disruption exposing subendothelial 
collagen fibres and promoting platelet aggregation, 
subsequent thrombosis and thromboembolism.3
Is Screening Necessary?
Given the possible catastrophic implications of 
these injuries, the very high stroke rate in this 
population, and the increased awareness amongst 
health care professionals, the following question has 
been raised among investigators: “Is it necessary to 
implement screening protocols for patients at high 
risk of these injuries?”
The argument proposed by some investigators, 
who disagree with the implementation of screening 
protocols, is that screening this population of 
patients is not very cost-effective, nor does it really 
affect the outcome. In addition, after exposing 
the patient to aggressive screening and the risks 
of invasive digital subtraction angiography, a 
decision on treatment with anticoagulation therapy, 
interventional angiography or surgery is not 
always feasible. This would be because of the other 
morbidities from which patients of blunt trauma 
usually suffer, such as head injuries.9
However, other investigators attempted 
to prove that aggressive screening and early 
intervention is indeed justified and cost-effective. 
In a prospective analysis, between January 1996 
and June 2004, Cothren et al., screened 727 
patients with blunt trauma who had injuries highly 
suspicious of an underlying BCVI, (according to 
comprehensive screening criteria) and underwent 
a 4-vessel cerebrovascular angiogram. Of these 
patients, 244 were identified as having BCVIs. 
Antithrombotic therapy was immediately started 
in the 187 asymptomatic patients who had no 
contraindications. Using the estimated stroke risk 
stratification according to the degree of carotid 
artery injury found on angiography [Table 1],10 
Table 1: Blunt cerebrovascular injuries grading scale
Injury grade Angiographic findings
I Luminal irregularity or a dissection/
intramural haematoma with <25% 
luminal narrowing
II Dissection or intramural haematoma of 




Source: Cothren, et al.10
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BCVIs among all blunt trauma patients identified in 
their institution.6 Using the Memphis criteria, 3.5% 
of patients were screened with BCVIs identified in 
29% of them. The overall incidence of BCVIs in this 
study was found to be 1.03%.11
Modalities of Screening
Screening criteria are based on recognising types 
of injury mechanisms that have been shown to be 
highly associated with BCVIs. The advent of multi-
slice computed tomography (CT) scanners has 
enabled eligible patients to undergo screening with 
a sensitivity and specificity that is comparable to 
angiography, the gold standard screening tool. The 
treatment of most injuries is anticoagulation and in 
some instances, wherever indicated, endovascular 
therapy might be the best choice.
digital subtraction angiography 
(dsa)
Digital subtraction angiography (DSA) is considered 
to be the gold-standard diagnostic modality to 
detect BCVIs12,13 yet it carries a risk of serious 
complications given that it is an invasive modality. 
The risks attributable to DSA are similar to those 
of stroke and haemorrhage. The latter limitations 
and the fact that DSA is expensive and technically 





Multidetector computed tomographic angiography 
(MDCTA) has emerged as a very convenient and 
effective screening tool for BCVI,15–19 especially 
after the advent of multidetector computed 
tomography (MDCT), with some studies reporting 
a sensitivity and specificity approaching that of 
DSA. In multitrauma patients, MDCT is routinely 
utilised to screen for injuries of the head, neck, spine, 
chest, abdomen and pelvic injuries. A MDCTA 
protocol to screen for BCVIs in high-risk patients 
is conveniently performed at the same time. It is 
also less expensive and non-invasive compared to 
DSA.14
In the literature, there only two prospective studies 
comparing single-slice computed tomographic 
angiography (CTA) and magnetic resonance 
antithrombotic therapy was able to avert ischaemic 
neurological events in 32 patients. The authors 
concluded that the ability of screening protocols 
to detect these patients who are at risk of stroke, 
and subsequently preventing it by antithrombotic 
therapy, decreases the long-term morbidity 
associated with strokes.10
Screening Criteria
So far, two well-established screening criteria for 
BCVIs exist, the modified Denver criteria and the 
Memphis criteria [Table 2].2 The Denver criteria 
was the first screening protocol to be established 
at the Denver Health Medical Centre and was 
later modified by its authors. Using this screening 
method, the percentage of patients who underwent 
screening during the time span of their study is 
4.8%, and BCVIs were identified in 18% of these 
patients, with an overall incidence of 0.86% of 
Table 2: Screening criteria for blunt cerebrovascular 
injuries 
Denver Criteria Memphis Criteria
Signs/symptoms
Arterial haemorrhage or 
expanding haematoma
Cervical spine fracture
Cervical bruit Neurological exam not 
explained by brain imaging
Focal neurological deficit Horner’s syndrome
Neurological exam 
inconsistent with head 
computed tomography 
(CT) findings
Le Forte II or III fracture 
pattern
Stroke on follow-up head 
CT
Basilar skull fracture with 
involvement of the carotid 
canal
Neck soft tissue injury 
(seatbelt sign or hanging or 
haematoma)
Risk factors
Le Forte II or III fracture 
pattern
Cervical spine fracture
Basilar skull fracture with 
involvement of the carotid 
canal
Diffuse axonal injury with 
Glasgow Coma Scale <6
Near hanging with anoxic 
brain injury
Source: Arthurs, et al.2
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angiography (MRA) to DSA which were done by 
the Denver and Memphis groups. In their studies, 
CTA had a sensitivity of 47–68% and a specificity of 
67–99%. CTA missed 55% of Grade I, 14% of Grade 
II, and 13% of Grade III injuries.11,12 The authors 
concluded in this study that CTA should only be 
used to diagnose BCVIs when DSA is not available. 
However, it is important to note that the CTA 
scanners used at that time were single slice CTAs, 
which along with other limitations such as timing 
contrast injection, image acquisition protocols, 
post-image processing delays (reformatting 
process), and inexperience with interpretation, 
might have accounted for the disappointing results 
in these two studies.14
In 2003, 16-slice MDCTs were widely available 
across the USA and so trauma surgeons found 
resistance to using DSA.2
In a study by Berne et al. in 2004, 486 patients, 
identified to be at risk of BCVIs, underwent 
CTA. Patients who had a negative study received 
no further cerebrovascular imaging and were 
monitored for cerebral ischaemic complications. 
Patients who had a positive CTA underwent DSA to 
confirm the findings. The results showed that CTA 
had a sensitivity of 100% and a specificity of 94.0% 
and none of the patients who had a negative CTA 
subsequently developed any ischaemic neurological 
events.20 These results were questioned because 
the patients who had a negative CTA were not 
confirmed to be true negatives by DSA. In the same 
year, Bub et al. published a retrospective analysis 
that included 32 patients who were suspected to 
have BCVIs and underwent both MDCTA and 
DSA. Results showed that 17 BCVIs were identified 
in 15 of the 32 patients. MDCTA done by three 
different radiologists had a sensitivity of 83–92% 
and specificity of 88–98% for detecting BCIs. 
However, the sensitivity for vertebral artery injuries 
ranged from 40–60%, and the specificity ranged 
from 90–97%.21 In 2006, three studies, published 
by three different institutes, produced very similar 
results with regard to the use of 16-slice MDCT 
to scan for BCVIs in high risk patients. All three 
groups found MDCT to be as accurate as DSA in 
detecting BCVIs,15,18,19 with the exception of one 
patient in the study done by Eastman et al., where 
a Grade 1 injury was missed by MDCT and was 
detected by DSA.19 In all three studies, none of the 
patients who was initially found to have a negative 
CTA later developed complications attributable to 
an undetected BCVI.
Although many of the studies discussed above 
do prove that the accuracy of CTA approaches that 
of DSA, the lack of prospective data comparing 
16-slice CTA to DSA and the small number of 
patients included in each study limit the reliability 
of the results and the validity of the conclusion 
that CTA is equivalent to DSA. It is recommended 
that patients who are at high risk for BCVIs should 
be considered for DSA regardless of their CTA 
findings, until a large, multicentre prospective trial 
proves the case.2,14 
magnetic resonance 
angiography (mra)
The advantage of MRA over MDCT is the fact that 
it does not carry the risk of ionising radiation or 
the use of contrast, but in a multi-trauma setting 
MRA is not really a feasible or practical option. The 
time needed for the patient to be taken to the MR 
suite, for the test to be performed and the number 
of personnel required to perform the study are all 
limitations to its accessibility in a multi-trauma 
setting. However, in two prospective analyses by 
the Denver and Memphis groups, which compared 
CTA and MRA to DSA in patients suspected to 
have BCVIs, MRA had a sensitivity of 50–75% and 
specificity of 67–100%.11,12 
sonography
Duplex ultrasound is a portable and inexpensive 
tool that is well established in monitoring 
and diagnosing non-traumatic cerebrovascular 
pathology. However, the fact that it is operator 
dependant, has a limited ability to visualise 
cerebral vasculature at the base of the skull and 
also to visualise minimal injuries and dissections 
that are not associated with disrupted flow, has 
limited its role in detecting BCVI.2,14 In the few 
studies performed to evaluate the accuracy of 
duplex ultrasound to detect BCVIs, results were 
disappointing, showing that duplex has a low 
sensitivity and specificity compared to DSA and 
that it missed injuries in patients who later on 
developed ischaemic complications attributable to 
these injuries.22,23
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for patients treated initially with anticoagulation 
for their BCVI in order to detect any 
subsequent development of pseudoaneurysms 
requiring surgical or endovascular interventions.24–34
antiplatelets therapy
Aspirin (and in few other reports, clopidogrel) 
has been used as an alternative to heparin in the 
treatment of patients with BCVI. It has been shown 
to have similar efficacy to heparin in preventing 
neurological events. In fact, aspirin has been 
proven to have a better safety profile with less risk 
of bleeding compared to heparin, especially in the 
population of trauma patients.11,26–28A combination 
therapy of anticoagulation and antiplatelets has been 
practised, but any advantage has not been proven; it 
definitely requires further prospective trials to elicit 
any added benefit to the single therapy.
open surgical repair
Direct surgical repair is advocated for discrete 
lesions at the carotid bifurcation or lesions below 
the base of the skull making it amenable for proximal 
and distal control. Most of the time, open surgical 
repair is rarely considered for patients with BCVI 
for the reasons mentioned above.3,7 Management 
of pseudoaneurysms is less controversial and most 
authors recommend surgical repair whenever it 
is technically feasible.24,29,33 Small or inaccessible 
pseudoaneurysms have been managed by 
anticoagulation with or without proximal ligation, 
or by the rarely used extracranial-intracranial 
bypass.7,35 
endovascular therapy
With the development of the less invasive 
endovascular techniques, most carotid 
pseudoaneurysms and dissection flaps that result 
from BCVI have been managed successfully 
with angioplasty and endoluminal stenting.36–38 
Endovascular therapy is an alternative to open 
surgical repair and of great value in the distal 
carotid lesions which are not amenable for open 
surgical repair. This therapy is recommended 
in cases where there is a contraindication for 
anticoagulation. Bare or covered stents, either 
balloon expandable or self-expanding, have been 
used extensively with good outcome and no further 
neurological events reported.36,39,40 As compared 
to data on peripheral stenting, antiplatelets 
Management
The early detection and treatment of BCVIs has 
been shown to reduce the morbidity and mortality 
related to these injuries. Both symptomatic and 
asymptomatic patients with BCVI should be 
managed and closely monitored for any neurological 
deterioration. The optimal treatment of patients with 
BCVI is not yet well established. The appropriate 
management of BCVI depends on the specific 
injury and its anatomic site.3,7,24–28 Controversies do 
exist in the management of dissection, thrombosis 
and pseudoaneurysm formations. Older studies 
prefer surgical over non-surgical management of 
dissection and thrombosis.29 However, most of 
these lesions extend beyond the skull base, and 
are therefore not amenable to open surgical repair. 
In addition, most neurologic sequelae of these 
injuries are related to acute thrombosis, thrombus 
propagation and distal embolisation, making 
surgical reconstruction irrelevant. There is therefore 
growing support for nonsurgical management of 
dissections and thromboses.13,29–32 Prospective trials 
comparing surgery with anticoagulation are not 
feasible.
anticoagulation therapy
Although its efficacy has not been proven, 
anticoagulation therapy has been considered 
the treatment of choice in patients with BCVI, 
especially for those with high located intimal 
flaps, extensive dissections and small inaccessible 
pseudoaneurysms. Anticoagulation is documented 
to prevent cerebral embolisation and to avoid 
permanent occlusions of injured vessels.3,7,25 
Li 29 and Parikh33 have suggested improvement of 
outcomes with anticoagulation alone. 
Initial systemic heparin therapy is safe and 
should be considered if no contraindications are 
present, or if the anticipated benefit outweighs the 
risk of bleeding in high risk patients. This should 
be followed by oral anticoagulation therapy with 
warfarin (Coumadin) for three to six months.3,7,25,28 
Reported complications of anticoagulation include 
intracranial haemorrhage, gastrointestinal bleeding, 
retroperitoneal haemorrhage, bleeding at the site 
of blunt solid organ injury and re-bleeding from 
surgical wounds. These complications are reported 
to occur in 25–54% of trauma patients.6
Most authors agree on the need for follow-up 
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therapy (aspirin and clopidogrel) is advised 
after endoluminal stent therapy to prevent stent 
thrombosis and embolic ischaemic events.41 Balloon 
occlusion techniques are a well established mode 
of treatment for carotid-cavernous sinus fistulae, 
and the results are fair to good.13,29–32 
Outcome
The prognosis of BCVI is generally poor. All 
reported cases of complete arterial disruption have 
been fatal. Other injuries of dissection, thrombosis 
and pseudoaneurysm formation carry variable 
outcomes depending on the site of the injury as 
well as the time of detection of these injuries. 
Mortality rates after BCVI have been reported to 
be 5–40% and reasonable neurologic recovery in 
only 20–60% of all survivors.13,29–32 Although there 
is some evidence to show improved outcomes 
with anticoagulation and antiplatelets therapy 
and in selected cases of surgical and endovascular 
interventions, the outcome of BCVI depends 
more on the speed of diagnosis.12,32,33 A high index 
of suspicion and the maintenance of aggressive 
evaluation protocols for patients with possible 
BCVI will definitely avoid diagnostic delay and may 
improve the overall outcome.  
Conclusion
Blunt cerebrovascular injury (BCVI) may be overtly 
present in more than 1% of patients with blunt 
trauma. Aggressive screening strategies uncover 
injuries in up to 44% of those screened. If not 
appropriately diagnosed and treated in a timely 
manner, many such injuries are responsible for 
significant morbidity and mortality. Aggressive 
screening protocols are now feasible using newer 
generation, multidetector helical scanners capable 
of detecting small intimal defects in a relatively 
non-invasive manner.
Treatment has focused on reducing the 
atheroembolic tendency of the disrupted vessel 
wall. Anticoagulation with heparin and anti-
platelet agents has been used; however, in a 
multitrauma patient, the risks of bleeding and the 
need for immediate surgery must be taken into 
account. Certain injuries to cervical vessels may 
be amenable to endovascular therapy. Therefore 
a multi-disciplinary team consisting of the 
emergency physician, trauma surgeon, vascular 
surgeon, interventional radiologist and intensivist 
is recommended for immediate and follow-up 
care. A high index of suspicion and maintaining 
aggressive evaluation protocols for patients with 
possible BCVI will definitely avoid diagnostic delay 
and may improve the overall outcome after BCVI. 
Further research into optimal treatment strategies 
is warranted.
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